Authors:
Hovind, P
Tarnow, L
Rossing, P
Teerlink, T
Stehouwer, CDA
Emeis, JJ
Parving, HH
Citation: P. Hovind et al., Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1, AM J KIDNEY, 38(6), 2001, pp. 1376-1380
Citation: Hh. Parving et P. Rossing, Therapeutic benefits of ACE inhibitors and other antihypertensive drugs inpatients with type 2 diabetes, DIABET CARE, 24(1), 2001, pp. 177-178
Authors:
Hovind, P
Rossing, P
Tarnow, L
Smidt, UM
Parving, HH
Citation: P. Hovind et al., Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively, KIDNEY INT, 60(1), 2001, pp. 277-283
Authors:
Myrup, B
Rossing, P
Jensen, T
Parving, HH
Holmer, G
Gram, J
Kluft, C
Jespersen, J
Citation: B. Myrup et al., Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy, SC J CL INV, 61(5), 2001, pp. 349-356
Authors:
Tarnow, L
Rossing, P
Jensen, C
Hansen, BV
Parving, HH
Citation: L. Tarnow et al., Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy, DIABET CARE, 23(12), 2000, pp. 1725-1730
Authors:
Tarnow, L
Fagerudd, JA
Rossing, P
Poirier, O
Nielsen, FS
Parving, HH
Citation: L. Tarnow et al., Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy, DIABET CARE, 23(1), 2000, pp. 30-33
Authors:
Bos, H
Andersen, S
Rossing, P
de Zeeuw, D
Parving, HH
de Jong, PE
Navis, G
Citation: H. Bos et al., Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy, KIDNEY INT, 57, 2000, pp. S32-S37
Authors:
Andersen, S
Tarnow, L
Rossing, P
Hansen, BV
Parving, HH
Citation: S. Andersen et al., Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy, KIDNEY INT, 57(2), 2000, pp. 601-606
Authors:
Christensen, PK
Gall, MA
Major-Pedersen, A
Sato, A
Rossing, P
Breum, L
Pietersen, A
Kastrup, J
Parving, HH
Citation: Pk. Christensen et al., QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes, SC J CL INV, 60(4), 2000, pp. 323-332
Authors:
Myrup, B
Rossing, P
Jensen, T
Gram, J
Kluft, C
Jespersen, J
Citation: B. Myrup et al., Concentration changes during venous occlusion of proteins with affinity for extracellular matrix in insulin-dependent diabetes mellitus - A sign of vascular damage in patients with diabetic nephropathy?, FIBRINOL PR, 13(3), 1999, pp. 142-147
Authors:
Nielsen, FS
Hansen, HP
Jacobsen, P
Rossing, P
Smidt, UM
Christensen, NJ
Pevet, P
Vivien-Roels, B
Parving, HH
Citation: Fs. Nielsen et al., Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy, DIABET MED, 16(7), 1999, pp. 555-562
Authors:
Christensen, PK
Rossing, P
Nielsen, FS
Parving, HH
Citation: Pk. Christensen et al., Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy, DIABET MED, 16(5), 1999, pp. 388-394
Authors:
Tarnow, L
Sato, A
Ali, S
Rossing, P
Nielsen, FS
Parving, HH
Citation: L. Tarnow et al., Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy, DIABET CARE, 22(3), 1999, pp. 491-494
Authors:
Sorensen, VB
Rossing, P
Tarnow, L
Parving, HH
Norgaard, T
Kastrup, J
Citation: Vb. Sorensen et al., Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy, CLIN SCI, 95(6), 1998, pp. 709-717